• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

POLL: Which Most Recent FDA Approval Are You Excited About?

Poll

Click here to answer this week's poll.

Which Most Recent FDA Approval Are You Excited About?

Sirolimus topical gel 0.2% for facial angiofibromas with tuberous sclerosis complex
Ruxolitinib cream 1.5% for nonsegmental vitiligo
Baricitinib for alopecia areata
Roflumilast cream 0.3% for plaque psoriasis
Ustekinumab for pediatric psoriatic arthritis
Hyaluronic acid filler for loss of jawline definition
Related Content
POLL: Would You Consider Utilizing Virtual Reality in Your Practice or to Further Your Education?

POLL: Would You Consider Utilizing Virtual Reality in Your Practice or to Further Your Education?

Article
What Conferences Are You Planning to Attend in Quarter 2 of 2024?

What Conferences Are You Planning to Attend in Quarter 2 of 2024?

Article
POLL: What Topic Do You Most Want Us to Cover at the American Academy of Dermatology Annual Meeting?

POLL: What Topic Do You Most Want Us to Cover at the American Academy of Dermatology Annual Meeting?

Article
POLL: Are You Attending the American Academy of Dermatology Annual Meeting?

POLL: Are You Attending the American Academy of Dermatology Annual Meeting?

Article
POLL: Which of These Rare Dermatologic Diseases Have You Encountered in Your Practice?

POLL: Which of These Rare Dermatologic Diseases Have You Encountered in Your Practice?

Article
Surveying Our Readers: What Are Your Thoughts on the New AAD Acne Guidelines?

Surveying Our Readers: What Are Your Thoughts on the New AAD Acne Guidelines?

Article
© 2024 MJH Life Sciences

All rights reserved.